Skip to content

Melinda S. Hancock

Trustee, term 2026-2028

Executive Vice President & Chief Financial Officer | Sentara Health

Last verified November 4, 2026

6 Red Flags
Affiliations
  • •EVP & CFO of Sentara Health (Virginia Beach, VA) since January 1, 2025, responsible for accounting, actuarial, revenue cycle, Medicare and Medicaid reimbursement, managed care contracting, treasury and investment portfolios.
  • •Previously Sentara's EVP & Chief Transformation Officer (2022-2024) and Chief Administrative Officer (from July 2021); before that CAO and CFO of VCU Health System, partner at Dixon Hughes Goodman, and Virginia-market CFO for Bon Secours.
  • •AHA Board of Trustees since January 1, 2026; former member of AHA Regional Policy Board 3 (2021-2023).
  • •Past National Chair of the Healthcare Financial Management Association (2015-2016); Fellow, HFMA; Virginia CPA.
  • •Board member of Phlow Corporation (an essential-medicines manufacturer), EvidenceCare, the Virginia Center for Health Innovation and the Sandler Center Foundation; trustee of the William & Mary Business School Foundation.
  • •Early career at Culpeper Regional Hospital and as an auditor and consultant with Ernst & Young and Deloitte.
Financial / Compensation
  • •Hancock received $2,005,794 in 2024 ($1,838,351 reportable plus $167,443 other) as EVP and Chief Transformation Officer, per Sentara Health's Form 990 filed November 6, 2025; her CFO-year (2025) pay is not yet public.
  • •Schedule J breakdown (FY2024, Sentara Health): base salary $877,864, bonus and incentive $923,895, other reportable $36,592, retirement and deferred $140,642, nontaxable benefits $26,801; total $2.01M. Bonus and incentive pay was 46% of the total.
  • •Her reported pay rose from about $1.46 million in 2022 to $1.71 million in 2023 and $2.01 million in 2024.
  • •CEO Dennis Matheis received $6.38 million in 2024 and outgoing CFO Robert Broermann $3.46 million on the same filing; total executive compensation at the Sentara Health parent was $24.8 million.
  • •Sentara reports $14.2 billion in 2025 operating revenue, 12 hospitals, a health plan with nearly 1 million members, and 34,700 employees.
  • •Sentara reports $382 million in community benefit for 2025 (including uncompensated care, prevention programs and medical education), about 2.7% of its operating revenue.
  • •The Sentara Health parent entity reported $7.24 billion in total assets and $5.24 billion in net assets for 2024, and its 990 discloses first-class or charter travel for executives.
  • •Sentara Hospitals, a separate filer, reported $3.99 billion in revenue and $494 million revenue over expenses for 2023.
Lobbying and Political
  • •Sentara retains The Vectre Corporation as its federal lobbyist, filing quarterly in 2025 and 2026 with no dollar amount reported, on Medicaid, Medicare and ACA exchange subsidies.
  • •Sentara's legislative affairs operation reports to EVP and Chief Administrative Officer Aubrey Layne, a former Virginia Secretary of Finance under Gov. Ralph Northam and Secretary of Transportation under Gov. Terry McAuliffe.
  • •Sentara is a leading member of the Virginia Hospital & Healthcare Association, whose HosPAC shares eligible contributions with AHAPAC, the AHA's federal PAC.
  • •The AHA, where Hancock is a trustee, reported $25.47 million in federal lobbying in 2025 and $14.39 million through Q3 2026, defending the 340B program, opposing site-neutral payment and resisting Medicaid cuts.
  • •Sentara has publicly blamed H.R. 1 (the 2025 reconciliation law) Medicaid and Medicare cuts in its 2026 rate fight with Anthem.
Revolving Door
  • •No government positions held by Hancock herself.
  • •Sentara's chief administrative officer, Aubrey Layne, came straight from the Virginia Cabinet in 2021 (Secretary of Finance, 2018-2021) and now runs Sentara's legislative affairs and its public Anthem fight.
  • •Hancock rose through the HFMA national chair role and AHA Regional Policy Board 3 into the AHA's top governing board, while running the CFO office that handles Medicare and Medicaid reimbursement.
Home System Record
  • •Sentara Health's charity care at cost was $93.7M (2024 hospital tax returns).
  • •Sentara Health has 4 340B contract pharmacy arrangements registered with HRSA (OPAIS registry, Sept. 29, 2026).
  • •Sentara owns Sentara Health Plans (formerly Optima Health), with nearly 1 million commercial, Medicaid and Medicare members in Virginia and Florida, making it both the dominant hospital system and a major insurer in much of Virginia.
  • •Sentara ended negotiations with Anthem Blue Cross Blue Shield of Virginia on Medicare Advantage, Medicaid and ACA plans after an October 1, 2026 deadline; about 380,000 Anthem members face Sentara going out of network on January 1, 2027 (Medicaid on January 28, 2027).
  • •Sentara says Anthem owes more than $105 million in overdue claims, refused $27 million under a 2025 billing settlement, and withheld $9.7 million by downcoding emergency visits; commercial talks continue.
  • •Sentara reorganized its hospital operations in 2026 into four market-based divisions, each with its own market president.
  • •In 2026 Sentara launched a venture with BAMF Health and expanded virtual care and home pharmacy in Northern Virginia, extending outpatient reach.
  • •The Checks and Balances Project filed an IRS Form 13909 complaint alleging Sentara's financial assistance policies were unclear and that it charged uninsured patients more than insured ones; no IRS action has been reported.
  • •Critics have long argued Sentara's competitive conduct contributed to the April 2021 closure of Bon Secours DePaul Medical Center in Norfolk, the region's highest charity-care hospital.
Litigation and Scrutiny
  • •Whistleblowers brought a False Claims Act case alleging Sentara Health Plans (formerly Optima) inflated 2018 ACA exchange premiums to draw higher federal subsidies; DOJ reviewed the case and declined to intervene, and the relators' complaint was filed on a September 23 (Sentara's page does not state the year).
  • •The federal district court dismissed the whistleblowers' claims with prejudice, per Sentara's statement updated August 1, 2026; no appeal has been reported.
  • •Sentara says it paid more than $98 million in medical loss ratio rebates to Virginia policyholders for the 2018 plan year, and Virginia's Bureau of Insurance found the 2018 rate increases actuarially reasonable.
  • •No other 2025 or 2026 settlements, antitrust actions or state AG actions against Sentara were found in available sources.

Red Flags

Hancock now runs managed care contracting and reimbursement for a system that owns both the dominant hospital network and a nearly 1-million-member health plan, and she helps set AHA policy on hospital prices.

Sentara is threatening to cut off about 380,000 Anthem members on January 1, 2027 over rates, while reporting $14.2 billion in revenue and only $382 million (2.7%) in community benefit.

Sentara's health plan arm faced a whistleblower False Claims Act suit alleging it inflated 2018 ACA premiums to collect higher federal subsidies; the case was dismissed with prejudice by August 2026 after DOJ declined to intervene, but Sentara itself says it rebated over $98 million in excess premiums for that single plan year.

Hancock's pay rose 37% in two years to $2.0 million in 2024, before her promotion to CFO; her CFO-year pay will appear on the 2025 Form 990.

Sentara's public affairs chief came directly from the Virginia governor's Cabinet, the clearest revolving door in the Sentara C-suite.

An IRS complaint alleging Sentara charged uninsured patients more than insured patients remains unresolved in the public record.

Pattern Summary

Hancock is the AHA board's purest finance insider: a CPA, former HFMA chair and now CFO of a vertically integrated system that is both payer and provider across much of Virginia. In 2026 Sentara used that leverage in a public rate war with Anthem, threatening out-of-network status for 380,000 members, and beat a False Claims suit over its 2018 ACA premiums. A $14 billion system reporting under 3% of revenue as community benefit is exactly what the AHA's tax-exemption defense is built to protect.